Proactive Investors - Run By Investors For Investors

VinaCapital Vietnam Opportunity Fund snaps up stake in mobile phone retailer

VOF has invested US$11mln into FPTR, which was the largest investment among a group of institutions
picture of iPhone
Smartphone penetration is expected to soar in rural Vietnam

VinaCapital Vietnam Opportunity Fund (LON:VOF) has taken a sizeable stake in FPT Digital Retail JSC (FPTR), a leading mobile phone distributor in Vietnam.  

VOF has invested US$11mln into FPTR, which was the largest investment among a group of institutions that have bought a 35% stake from the mobile phone group’s parent FPT Group.

WATCH: Vina Capital answers the call to invest in Vietnam's mobile market

As part of the sale, FPT has committed to list FPTR in the future.

VOF is managed by Vinaland, which also manages AIM-listed VinaLand Limited (LON:VNL) and Vietnam Infrastructure Limited (LON:VNI).

Andy Ho, chief investment officer of VinaCapital and managing director of VOF, said: “The consumer sector is one our favourites, and Vietnamese people have shown a huge appetite for mobile phones and accessories, which is their primary tool to communicate and access the internet.

"This transaction enables us to make a meaningful investment in a premier, unlisted company at a substantial discount compared to the market and peers.”

READ: VinaCapital fund snaps up stake in Vietnam toll-road operator

FPT Retail is the second-largest mobile phone shop chain in Vietnam, with 14% market share nationwide and 443 stores covering all 63 provinces in the country.

Compounded annual growth in revenue and profit before tax is expected to be over 25% and 35% per annum, respectively, during the 2016 – 2019 period as smart phone penetration increase in Vietnam’s provinces.

View full VOF profile View Profile

VinaCapital Vietnam Opportunity Fund Limited Timeline

Related Articles

Blood cells
October 12 2017
Current standard of care treatment involves chemotherapy and radiotherapy and ultimately, in recurring cases, a bone marrow transplant
cannabis plant
February 01 2018
Today, the group closed the US$18mln acquisition of Citiva Medical and Citiva USA

No investment advice

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is suitable or advisable for any specific person. You further understand that none of the information providers or their affiliates will advise you personally concerning the nature, potential, advisability, value or suitability of any particular security, portfolio of securities, transaction, investment strategy, or other matter.

You understand that the Site may contain opinions from time to time with regard to securities mentioned in other products, including company related products, and that those opinions may be different from those obtained by using another product related to the Company. You understand and agree that contributors may write about securities in which they or their firms have a position, and that they may trade such securities for their own account. In cases where the position is held at the time of publication and such position is known to the Company, appropriate disclosure is made. However, you understand and agree that at the time of any transaction that you make, one or more contributors may have a position in the securities written about. You understand that price and other data is supplied by sources believed to be reliable, that the calculations herein are made using such data, and that neither such data nor such calculations are guaranteed by these sources, the Company, the information providers or any other person or entity, and may not be complete or accurate.

From time to time, reference may be made in our marketing materials to prior articles and opinions we have published. These references may be selective, may reference only a portion of an article or recommendation, and are likely not to be current. As markets change continuously, previously published information and data may not be current and should not be relied upon.

© Proactive Investors 2018

Proactive Investors Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use